Evaluate Human-Specific Immunotherapies In Vivo

Immunotherapies have demonstrated considerable success in oncology research, treating a variety of cancer types by taking advantage of a patient’s own immune system. However, a lack of experimental, preclinical immuno-oncology models is hindering immunotherapy development.